Teva announces launch of an authorized generic of epiduo® forte gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the u.s.

Tel aviv & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), today announced the launch of an authorized generic of epiduo®1 forte gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the united states. adapalene and benzoyl peroxide gel 0.3%/2.5% is a topical prescription medicine used to treat acne vulgaris. “the launch of our first-to-market authorized generic version of epiduo® forte gel in the u.s. prov
TEVA Ratings Summary
TEVA Quant Ranking